Cryobiopsy for diagnosing progressive pulmonary fibrosis
Part of Lungs & breathing clinical trials.
This trial is testing a new, less invasive way to take a lung tissue sample (called transbronchial cryobiopsy) to help diagnose progressive pulmonary fibrosis (PPF). It may help doctors find the cause of your lung scarring without needing a larger surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with progressive pulmonary fibrosis (PPF) or an unclassified interstitial lung disease (ILD).
- Your lung function tests show that your forced vital capacity (FVC) is at least 50% of normal, and your carbon monoxide diffusion (DLCO) is at least 35% of normal.
- You have had a high-resolution CT scan (HRCT) of your chest in the last 3 months.
- Your blood clotting is normal (platelet count above 50,000 and INR below 1.5), and you do not have high blood pressure in your lungs (pulmonary artery pressure below 40 mmHg).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a single lung scan to find early signs of progressive scarring (fibrosis) in people with pulmonary fibrosis. It may help doctors predict which patients will get worse faster.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study is testing a new way to track lung scarring (fibrosis) over time in people with conditions like IPF, other fibrotic lung diseases, or early signs of scarring. It might help doctors understand how the disease changes.
This trial studies whether standardizing the training for a lung biopsy procedure helps doctors better diagnose interstitial lung disease. You might be eligible if you have a suspected ILD diagnosis and your lung function and other health markers are within certain limits.
This study is a registry that collects information from people in China who have progressive pulmonary fibrosis (PPF), a lung condition that gets worse over time. It aims to better understand the disease and help doctors improve care.
This study tests a new way to get tissue samples from small lung nodules using a special scope and freezing technique. It may help diagnose cancer without more invasive procedures.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.